No Detail Found!

Ketotifen, an anti-asthmatic drug protects platelet-activating factor-induced sudden death in rabbits.

Author(s)
Sheikh A. Saeed Pharmacology Department, The Aga Khan University, Faculty of Health Science, Karachi, Pakistan
Shameem J. Karimi Pharmacology Department, The Aga Khan University, Faculty of Health Science, Karachi, Pakistan
Akhtar Naqvi Sandoz Pakistan Limited, Karachi, Pakistan
Maqbool H. Jafary Sandoz Pakistan Limited, Karachi, Pakistan
Abstract
The effects of antiasthmatic drug; ketotifen on human platelet aggregation induced by platelet-activating factor (PAF), ADP, collagen and arachidonic acid (AA) have been investigated. Ketotifen selectively inhibited (at 0.04-4uM concentration) PAF-induced aggregation. Whereas other anti-asthma drugs such as sodium cromoglycate, theophyllline and salbutamol had no effect. Similarly, ketotifen also inhibited the lethal effects of PAF in the rabbit. PAF (8-11 ug/Kg i.v.) caused sudden death in rabbits due to platelet aggregation. Pretreatment of rabbits with ketotifen (1 mg/kg i.p.) protected conscious rabbits from PAF (11 ug/kg i.v.) induced death. Since PAF membrane receptors, the data is suggestive that ketotifen acts as a PAF antagonist in platelet aggregation.
Publication Details
Page(s) 67-74
DOI DOI not available
Published Journal: Pakistan Journal of Pharmacology, Volume: 6, Issue: 1--2, Year: 1989

Request the full text from PASTIC

0

Citations

0

Downloads

116

Views